CN114129669A - 一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂 - Google Patents
一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂 Download PDFInfo
- Publication number
- CN114129669A CN114129669A CN202111469225.8A CN202111469225A CN114129669A CN 114129669 A CN114129669 A CN 114129669A CN 202111469225 A CN202111469225 A CN 202111469225A CN 114129669 A CN114129669 A CN 114129669A
- Authority
- CN
- China
- Prior art keywords
- parts
- cataplasm
- patch
- treating rheumatism
- paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 claims abstract description 48
- 244000107975 Strychnos nux-vomica Species 0.000 claims abstract description 43
- 238000002156 mixing Methods 0.000 claims abstract description 41
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 28
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 28
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 28
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 27
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 27
- 210000001320 hippocampus Anatomy 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 25
- 244000189799 Asimina triloba Species 0.000 claims abstract description 24
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 24
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 24
- 239000004863 Frankincense Substances 0.000 claims abstract description 24
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 24
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 24
- 239000000284 extract Substances 0.000 claims abstract description 24
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 23
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 23
- 235000011477 liquorice Nutrition 0.000 claims abstract description 23
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 22
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 22
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 22
- 241000951473 Schizonepeta Species 0.000 claims abstract description 22
- 240000000031 Achyranthes bidentata Species 0.000 claims abstract description 21
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 21
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 21
- 239000000706 filtrate Substances 0.000 claims abstract description 21
- 244000237330 gutta percha tree Species 0.000 claims abstract description 20
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 19
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940116229 borneol Drugs 0.000 claims abstract description 19
- 229930008380 camphor Natural products 0.000 claims abstract description 19
- 229960000846 camphor Drugs 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 18
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 18
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 17
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 238000004513 sizing Methods 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 65
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 61
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 36
- 229920001971 elastomer Polymers 0.000 claims description 36
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 36
- 239000005060 rubber Substances 0.000 claims description 36
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 25
- 235000011187 glycerol Nutrition 0.000 claims description 23
- 235000002906 tartaric acid Nutrition 0.000 claims description 23
- 239000011975 tartaric acid Substances 0.000 claims description 23
- 239000003502 gasoline Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 20
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 20
- 108010010803 Gelatin Proteins 0.000 claims description 19
- 239000008273 gelatin Substances 0.000 claims description 19
- 229920000159 gelatin Polymers 0.000 claims description 19
- 235000019322 gelatine Nutrition 0.000 claims description 19
- 235000011852 gelatine desserts Nutrition 0.000 claims description 19
- 239000011787 zinc oxide Substances 0.000 claims description 18
- 244000170916 Paeonia officinalis Species 0.000 claims description 17
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 17
- 229960001047 methyl salicylate Drugs 0.000 claims description 17
- 229940099259 vaseline Drugs 0.000 claims description 17
- 229960001296 zinc oxide Drugs 0.000 claims description 17
- 241001180876 Saposhnikovia Species 0.000 claims description 15
- 239000004166 Lanolin Substances 0.000 claims description 13
- 239000000654 additive Substances 0.000 claims description 13
- 230000000996 additive effect Effects 0.000 claims description 13
- 229940039717 lanolin Drugs 0.000 claims description 13
- 235000019388 lanolin Nutrition 0.000 claims description 13
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 11
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 11
- 229940043266 rosin Drugs 0.000 claims description 11
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 11
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 10
- 235000010489 acacia gum Nutrition 0.000 claims description 10
- 238000003892 spreading Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 241000305491 Gastrodia elata Species 0.000 claims description 8
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 7
- 229910052782 aluminium Inorganic materials 0.000 claims description 7
- 241000382455 Angelica sinensis Species 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 5
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 claims description 4
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 claims description 4
- 241001559542 Hippocampus hippocampus Species 0.000 claims description 4
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 claims description 4
- RBNPZEHAODHBPZ-UHFFFAOYSA-M dihydroxyaluminium Chemical compound O.O.NCC(=O)O[Al] RBNPZEHAODHBPZ-UHFFFAOYSA-M 0.000 claims description 4
- 238000005325 percolation Methods 0.000 claims description 4
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 235000010210 aluminium Nutrition 0.000 claims description 3
- 210000002268 wool Anatomy 0.000 claims description 3
- 244000215068 Acacia senegal Species 0.000 claims description 2
- KUOCVULFPYEBAB-UHFFFAOYSA-K C(C(O)CO)(=O)[O-].O[Al+]O Chemical compound C(C(O)CO)(=O)[O-].O[Al+]O KUOCVULFPYEBAB-UHFFFAOYSA-K 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 61
- 230000000694 effects Effects 0.000 abstract description 43
- 208000002193 Pain Diseases 0.000 abstract description 32
- 230000036407 pain Effects 0.000 abstract description 32
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 12
- 230000009286 beneficial effect Effects 0.000 abstract description 11
- 239000012466 permeate Substances 0.000 abstract description 3
- 239000011248 coating agent Substances 0.000 abstract description 2
- 238000000576 coating method Methods 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 description 46
- 229960004063 propylene glycol Drugs 0.000 description 17
- 235000013772 propylene glycol Nutrition 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 16
- 241000723347 Cinnamomum Species 0.000 description 14
- 239000002671 adjuvant Substances 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 13
- 208000006820 Arthralgia Diseases 0.000 description 12
- 241000721047 Danaus plexippus Species 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 10
- 230000001976 improved effect Effects 0.000 description 10
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 241000427159 Achyranthes Species 0.000 description 9
- 240000007472 Leucaena leucocephala Species 0.000 description 9
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 241001416180 Moschidae Species 0.000 description 8
- 241000717739 Boswellia sacra Species 0.000 description 7
- 208000025747 Rheumatic disease Diseases 0.000 description 7
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 7
- 229940025250 camphora Drugs 0.000 description 7
- 239000010238 camphora Substances 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000000552 rheumatic effect Effects 0.000 description 7
- 244000153234 Hibiscus abelmoschus Species 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 238000007605 air drying Methods 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 238000010298 pulverizing process Methods 0.000 description 6
- 235000019633 pungent taste Nutrition 0.000 description 6
- 241001279009 Strychnos toxifera Species 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 229960005453 strychnine Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000011505 plaster Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 241000208173 Apiaceae Species 0.000 description 3
- 241000218195 Lauraceae Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000208229 Burseraceae Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000208688 Eucommia Species 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- 229920000715 Mucilage Polymers 0.000 description 2
- 241001057584 Myrrha Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 244000024893 Amaranthus tricolor Species 0.000 description 1
- 235000014748 Amaranthus tricolor Nutrition 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 241000158621 Brucea Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 240000000425 Chaenomeles speciosa Species 0.000 description 1
- 235000005078 Chaenomeles speciosa Nutrition 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001559433 Hippocampus kelloggi Species 0.000 description 1
- 241001559417 Hippocampus trimaculatus Species 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000218164 Menispermaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001113787 Strychnos Species 0.000 description 1
- 241001247203 Syngnathidae Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- -1 i.e. Chemical compound 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000144 sodium(I) superoxide Inorganic materials 0.000 description 1
- REFMEZARFCPESH-UHFFFAOYSA-M sodium;heptane-1-sulfonate Chemical compound [Na+].CCCCCCCS([O-])(=O)=O REFMEZARFCPESH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Marine Sciences & Fisheries (AREA)
Abstract
本发明提出了一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂,涉及中药配方技术领域。该制备方法包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并渗漉,得到渗漉液,将渗漉液与滤液混合并浓缩,得到浸膏,向浸膏内加入樟脑、麝香和冰片制成膏体,将膏体与胶料混合后涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂;该制备方法通过将各原料中的有益组分充分提取出来,从而增大所制得的巴布贴剂的疗效,不仅方便外涂,而且还方便该巴布贴剂通过皮肤渗入患者关节处,起到祛风散寒、活血止痛的效果。
Description
技术领域
本发明涉及中药配方技术领域,具体而言,涉及一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂。
背景技术
在中医方面,风湿痹病是由于风寒湿热等外邪入侵,闭阻经络关节,气血运行不畅,主要临床表现为全身关节呈游走性红、肿、重着、疼痛。现目前在,风湿痹病的治疗通常从内服、外用和手术等三个方面去进行治疗,然而目前内服通常只能对风湿痹病起到改善的效果,无法根治,而手术的风险又比较大,如果手术失败,容易给患者造成不可逆的损伤。因此,通常使用外用的手段对风湿痹病进行治疗,然而目前外用药物给患者带来的体验较差,不仅疗程长,而且疼痛感较强。
因此,急需提供一种能够给风湿痹病患者带来更好体验的外用药物。
发明内容
本发明的第一目的在于提供一种用于治疗风湿的巴布贴剂的制备方法,该制备方法通过将各原料中的有益组分充分提取出来,从而增大所制得的巴布贴剂的疗效,并且该制备方法将巴布贴剂制备成膏体,不仅方便外涂,而且还方便该巴布贴剂通过皮肤渗入患者关节处,从而起到祛风散寒、活血止痛的效果。
本发明的第二目的在于提供一种用于治疗风湿的巴布贴剂,该巴布贴剂不仅能够有效治疗风湿痹痛,还能够降低该巴布贴剂的刺激性,从而提高用户的体验度。
本发明解决其技术问题是采用以下技术方案来实现的。
一方面,本申请实施例提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并渗漉,得到渗漉液,将渗漉液与滤液混合并浓缩,得到浸膏,向浸膏内加入樟脑、麝香和冰片制成膏体,将膏体与胶料混合后涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。该方法通过加入菌液对马钱子进行发酵,以降低马钱子的毒性和刺激性,方便患者敷用,并通过加入酸液酸化、碱液碱化和氯仿萃取以对马钱子中的生物碱进行提纯,从而增大所制得的巴布贴剂中有益成分的浓度,进而提高巴布贴剂的疗效。
另一方面,本申请实施例提供一种用于治疗风湿的巴布贴剂,包括按重量分数计的如下原料,马钱子250-350份、荆芥25-35份、当归55-65份、红花25-35份、牛膝25-35份、木瓜25-35份、防已25-35份、赤芍25-35份、防风40-50份、甘草25-35份、川芎25-35份、天麻25-35份、杜仲25-35份、没药40-50份、肉桂10-20份、乳香40-50份、海马4-8份、樟脑20-30份、麝香10-15份、胶料4105-4920份和冰片45-55份。
上述各原料之间以合理的君臣佐使关系进行配伍,其中君药为马钱子和当归,其中马钱子性寒,主要具有通络止痛的功效,当归性温,主要具有活血驱寒的功效,二者相结合使用根据其一阴一阳的配合关系能够使二者的药性相中和,从而使药性更加平和,以避免在外用时对人体造成刺激,从而降低患者使用时的痛感。其中臣药为荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂、乳香和海马,其中臣药主要起到辅助君药的作用,进而增大该贴剂的疗效,臣药性微温,以祛风散寒,进而治疗风湿痹病;佐药为樟脑和麝香,佐药主要分为佐助药、佐制药和反佐药,本发明的实施例中,该佐药主要为佐助药,以辅助君药发挥效果,从而增大君药活血通络的效果,佐药性温,以祛风散寒;使药为冰片,冰片性微寒,用于调和臣药和使药的药性,使臣药和使药的药性趋于平和,进而与君药相匹配。
相对于现有技术,本发明的实施例至少具有如下优点或有益效果:
一、本发明的实施例提供了一种用于治疗风湿的巴布贴剂的制备方法,该方法通过加入菌液对马钱子进行发酵,以降低马钱子的毒性和刺激性,方便患者敷用,并通过加入酸液酸化、碱液碱化和氯仿萃取以对马钱子中的生物碱进行提纯,从而增大所制得的巴布贴剂中有益成分的浓度,进而提高巴布贴剂的疗效。
二、本发明的实施例还提供了一种用于治疗风湿的巴布贴剂,该巴布贴剂通过合理的君臣佐使关系进行配伍,从而在保证了该贴剂具有较好的祛风除湿、活血通络效果的同时,还能够降低该贴剂的刺激性,从而降低患者使用时的痛感,并且由于该贴剂还能够起到强筋健骨的作用,因此能够缩短患者的治疗疗程,进而加快患者的康复时间。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
需要说明的是,在不冲突的情况下,本申请中的实施例及实施例中的特征可以相互组合。下面将参考具体实施例来详细说明本发明。
一方面,本申请实施例还提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并渗漉,得到渗漉液,将渗漉液与滤液混合并浓缩,得到浸膏,向浸膏内加入樟脑、麝香和冰片制成膏体,将膏体与胶料混合后涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。该制备方法通过将各原料中的有益组分充分提取出来,从而增大所制得的巴布贴剂的疗效,并且该制备方法将巴布贴剂制备成膏体,不仅方便外涂,而且还方便该巴布贴剂通过皮肤渗入患者关节处,从而起到祛风散寒、活血止痛的效果。
在本发明的一些实施例中,上述胶料包括如下原料,橡胶、明胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、阿拉伯胶和汽油;胶料制备包括如下步骤,将橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混合后搅匀,即得到胶料。
在本发明的一些实施例中,上述制成膏体还包括加入添加剂,加入添加剂包括如下步骤,将添加剂、浸膏、樟脑、麝香和冰片混匀后即得到膏体;添加剂包括如下原料,羊毛脂、氧化锌、凡士林、松香和水杨酸甲酯。通过加入添加剂以提高该组合物的舒适度、香味以及药性等,进而提高患者的使用体验,降低刺激感的同时,并保证该组合物的药性足够。
在本发明的一些实施例中,上述渗漉采用85-95%的乙醇溶液。渗漉是将适度粉碎的药材置渗漉筒中,由上部不断添加溶剂,溶剂渗过药材层向下流动过程中浸出药材成分的方法,选用85-95%的乙醇作为溶剂,以充分萃取出药材中的有益成分,进而增大该组合物的药性。
在本发明的一些实施例中,上述浸膏的相对密度在60℃时为1.03-1.10。该相对密度区间能够使所制得的贴剂具有足够有益成分的同时,又不会导致该贴剂的体积过大,而给患者造成使用不便。
另一方面,本申请实施例提供一种用于治疗风湿的巴布贴剂,包括按重量分数计的如下原料,马钱子250-350份、荆芥25-35份、当归55-65份、红花25-35份、牛膝25-35份、木瓜25-35份、防已25-35份、赤芍25-35份、防风40-50份、甘草25-35份、川芎25-35份、天麻25-35份、杜仲25-35份、没药40-50份、肉桂10-20份、乳香40-50份、海马4-8份、樟脑20-30份、麝香10-15份、胶料4105-4920份和冰片45-55份。其中,马钱子为马钱科马钱子属植物马钱的干燥成熟种子,别名番木鳖等,味苦,性寒,归肝、脾经,具有散结消肿,通络止痛的功效,主治跌打损伤,骨折肿痛,痈疽疮毒,咽喉肿痛,风湿顽痹和麻木瘫痪等症状,其中马钱子分为生马钱子和炒制后的马钱子等,本发明的实施例中多采用生马钱子,生马钱子未经过处理,能够保留其原始的药性,从而避免马钱子的药性损伤;荆芥为唇形科植物荆芥的干燥地上部分,别名假苏等,味辛,性微温,归肺、肝经,具有解表散风等功效,主治感冒,头痛,麻疹,风疹和疮疡等症状;当归为伞形科植物当归的干燥根,别名干归等,味甘、辛,性温,归肝、心、脾经,具有补血活血,调经止痛,润肠通便等功效,主治血虚萎黄,风湿痹痛等症状;红花为菊科植物红花的干燥花,别名草红花等,味辛,性温,归心、肝经,具有活血通经,散瘀止痛等功效,主治胸痹心痛等症状;牛膝为苋科植物牛膝的干燥根,别名山苋菜等,味苦、甘、酸,性平,归肝、肾经,具有逐瘀通经、强筋健骨等功效,主治腰膝酸痛和筋骨无力等症状,其中牛膝主要分为川牛膝和怀牛膝等,在本发明的实施例中主要使用怀牛膝,怀牛膝相比川牛膝强筋健骨的功效更强,能够加快风湿痹痛患者的康复速度,进而缩短治疗疗程;木瓜为蔷薇科植物贴梗海棠的干燥近成熟果实,别名铁脚梨等,味酸,性温,归肝、脾经,有舒筋活络等功效,主治湿痹拘挛和腰膝关节酸重疼痛等症状;防已为防己科植物粉防己的干燥根,味辛、苦,性寒,归膀胱、肺经,具有祛风止痛、利水消肿等功效,主治风湿痹痛等症状;赤芍为毛茛科植物芍药或川赤芍的干燥根,别名草芍药等,味苦,性微寒,归肝经,有清热凉血,散瘀止痛等功效,主治跌扑损伤和气血不调等症状;防风为伞形科植物防风的根,别名回云等,味辛、甘,性微温,归膀胱、脾、肝经,具有祛风解表,胜湿止痛等功效,主治风疹瘙痒,风湿痹痛等症状;甘草为豆科植物甘草、胀果甘草或光果甘草的干燥根和根茎,别名甜草根等,味甘,性平,归心、肺、脾和胃经,具有补脾益气、缓急止痛和缓解其他药物毒性等功效,主治四肢挛急疼痛等症状;川芎为伞形科植物川芎的根茎,别名马衔等,性温,味辛,归肝经、胆经、心包经,具有活血行气,祛风止痛等功效,主治气血不调和风湿痹痛等症状;天麻为兰科植物天麻的干燥块茎,味甘,性平,归肝经,具有息风止痉,平抑肝阳,祛风通络等功效,主治手足不遂,风湿痹痛等症状;杜仲为杜仲科植物杜仲的树皮,别名木棉等,味甘、微辛,性温,具有强筋骨、补肝肾等功效,主治腰脊酸疼、足膝痿弱等症状;没药为橄榄科植物地丁树或哈地丁树的干燥树脂,别名末药等,味辛、苦,性平,归心、肝、脾经,具有散瘀定痛,消肿生肌等功效,主治胸痹心痛、风湿痹痛等症状;为樟科植物肉桂的干燥树皮,别名紫桂等,味辛、甘,性大热,归肾、脾、心、肝经,具有散寒止痛,温通经脉的功效,主治腰膝冷痛、风湿痹痛等症状;乳香为橄榄科植物乳香树及同属植物树皮渗出的树脂,别名乳头香等,味辛、苦,性温,归心、肝、脾经,具有活血行气止痛、消肿生肌等功效,主治风湿痹痛,筋脉拘挛等症状;海马来源于海龙科动物线纹海马、刺海马、大海马、三斑海马和小海马的全体,别名龙落子等,性温,味甘、咸,归肝经、肾经,具有温肾壮阳、散结消肿等功效,主治痈肿疔疮、风湿痹痛等症状;樟脑为樟科樟属植物樟的根、干、枝、叶经蒸馏精制而成的颗粒状物,别名油脑等,味辛,性温,入心、脾经,具有消肿止痛、通滞气等功效,主治寒湿脚气、跌打肿痛等症状;麝香原为鹿科动物林麝、马麝或原麝成熟雄体香囊中的干燥分泌物,但由于现目前林麝、马麝和原麝的数量都较为稀少,因此为了既保护动物,又能保证麝香的用量,在本发明的实施例中采用人工合成的人工麝香进行代替;人工麝香与天然麝香的效果基本类似,味辛,性温;归心、脾经,具有活血通经,消肿止痛等功效,主治风寒湿痹、跌打损伤等症状;冰片由菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸汽蒸馏并重结晶而得,别名片脑等,化学成分为2-茨醇,化学式为C10H18O,味辛、苦,性微寒,归心、脾,肺经,具有清热散毒等功效,主治热毒郁结等症状。
上述各原料之间以合理的君臣佐使关系进行配伍,其中君药为马钱子和当归,其中马钱子性寒,主要具有通络止痛的功效,当归性温,主要具有活血驱寒的功效,二者相结合使用根据其一阴一阳的配合关系能够使二者的药性相中和,从而使药性更加平和,以避免在外用时对人体造成刺激,从而降低患者使用时的痛感。其中臣药为荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂、乳香和海马,其中臣药主要起到辅助君药的作用,进而增大该贴剂的疗效,臣药性微温,以祛风散寒,进而治疗风湿痹病;佐药为樟脑和麝香,佐药主要分为佐助药、佐制药和反佐药,本发明的实施例中,该佐药主要为佐助药,以辅助君药发挥效果,从而增大君药活血通络的效果,佐药性温,以祛风散寒;使药为冰片,冰片性微寒,用于调和臣药和使药的药性,使臣药和使药的药性趋于平和,进而与君药相匹配。
在本发明的一些实施例中,上述用于治疗风湿的巴布贴剂还包括辅料,辅料包括按重量份数计的如下原料,橡胶900-1100份、阿拉伯胶200-300份、聚丙烯酸钠10-20份、甘油15-30份、酒石酸10-30份、甘羟铝10-20份、丙二醇10-20份、明胶150-200份和汽油2800-3200份。其中通过添加橡胶以将便于后续将该贴剂制备成橡胶膏剂,橡胶膏剂指药物或药材提取物与橡胶为主的基质混合后,涂布于裱背材料上的外用剂型,橡胶膏剂主要有以下优点:橡胶膏剂粘着力强,不预热可直接贴于皮肤;不污染衣物,携带使用方便。而通过添加汽油不仅便于橡胶膏剂成膏,而且还能够作为萃取剂以提取部分药材中的有益成分,进而保证药材中的有益物质能够充分发挥。其中海马就通过汽油进行萃取,萃取完毕后回收萃取后的汽油以节约资源,从而有利于环保,且其中明胶和阿拉伯胶能够增大所制得的膏体的粘性,保证膏体能够紧密贴合人体。聚丙烯酸钠,化学式为(C3H3NaO2)n,是一种新型功能高分子材料和重要化工产品,固态产品为白色或浅黄色块状或粉末,液态产品为无色或淡黄色粘稠液体,其用量会影响所制得的巴布贴剂的皮肤舒适性、黏度和涂展性,其用量过低,会导致所制得的巴布贴剂的黏度较低,其用量过高则会导致所制得的巴布贴剂在使用时使人体皮肤的舒适性下降。甘油,即丙三醇,其具有良好的保湿功能,能够有效提高皮肤的舒适程度,当甘油使用量较低时,会导致所制得的巴布贴剂的涂展性降低,而当甘油的使用量较高时,则会导致所制得的巴布贴剂对人体皮肤舒适性下降。酒石酸,即2,3-二羟基丁二酸,是一种羧酸,化学式为C4H6O6,当酒石酸的用量过低,会导致所制得的巴布贴剂的涂展性较低,当酒石酸的用量过高,则会导致所制得的巴布贴剂的均匀性较差,从而导致黏性较低。甘羟铝,其化学名为二羟基氨基乙酸铝,其在贴剂中主要用作交联剂,主要与胶料的黏结力等性能有关,当甘羟铝的用量过低时,所制得的胶料的粘附性较低,会导致使用过程中有胶料脱落,而当甘羟铝的用量过高时,则会导致所制得的胶料对人体皮肤的舒适性降低。丙二醇,分子式为C3H8O2,一般存在两种稳定的同分异构体,在本发明中所使用的为1,2-丙二醇,其具有保湿和防冻作用,当丙二醇的用量过低时,则会导致所制得的巴布贴剂对人体皮肤的舒适程度降低,当丙二醇的用量过高时,则会导致所制得的巴布贴剂的粘附性降低。
在本发明的一些实施例中,上述用于治疗风湿的巴布贴剂还包括添加剂,添加剂包括按重量份数计的如下原料,羊毛脂100-150份、氧化锌1000-1250份、凡士林200-300份、松香1000-1050份和水杨酸甲酯20-30份。其中水杨酸甲酯,即邻羟基苯甲酸甲酯,分子式为C8H8O3,分子量为152.15,其具有强烈的冬青油香气,主要用于为该贴剂增甜香味,从而提高患者的使用体验。羊毛脂是附着在羊毛上的一种分泌油脂,主要成分是甾醇类、脂肪醇类和三萜烯醇类与大约等量的脂肪酸所生成的酯,约占95%,还含有游离醇4%,并有少量的游离脂肪酸和烃类物质,羊毛脂主要能够滋润皮肤,并且能够使该贴剂迅速被粘膜及皮肤吸收,有附着力,性质稳定,且能吸水,不易酸败,从而便于该贴剂的贮藏。氧化锌的化学式为ZnO,是一种锌的氧化物,其主要作为本发明中所制得的橡皮膏的收敛药,具有安神固本的效果,以使患者在使用时心情放松,从而提高患者的使用体验;凡士林是一种烷系烃或饱和烃类半液态的混合物,也叫矿脂,由石油分馏后制得,其主要作为所制得的橡胶膏的基质,从而保证橡胶膏的柔软度以及与人体皮肤贴合的舒适程度;松香为松科松属若干植物中渗出的油树脂,经蒸馏或提取除去挥发油后所余固体树脂,别名松脂等,不仅能够辅助前述所制得的贴剂发挥祛风燥湿、生肌止痛的功效,还能够增大所制得的橡胶膏的粘度。
在本发明的一些实施例中,上述用于治疗风湿的巴布贴剂包括如下重量份原料,马钱子300份、荆芥30份、当归60份、红花30份、牛膝30份、木瓜30份、防已30份、赤芍30份、防风45份、甘草30份、川芎30份、天麻30份、杜仲30份、没药45份、肉桂15份、乳香45份、海马6份、樟脑25份、麝香12.5份、冰片50份、水杨酸甲酯25份、橡胶1000份、汽油3000份、明胶175份、聚丙烯酸钠15份、甘油20份、酒石酸20份、甘羟铝15份、丙二醇15份、阿拉伯胶250份、毛脂125份、氧化锌1125份、凡士林250份和松香1025份。该比例数值是较为优选的比例区间,从而能够有效增大该贴剂的药性,并且在保证足够药性的同时还保证了刺激性较小,进而提高了患者的使用体验。
以下结合实施例对本发明的特征和性能作进一步的详细描述。
实施例1
本实施例提供了一种用于治疗风湿的巴布贴剂,包括如下原料,马钱子250g、荆芥25g、当归55g、红花25g、牛膝25g、木瓜25g、防已25g、赤芍25g、防风40g、甘草25g、川芎25g、天麻25g、杜仲25g、没药40g、肉桂10g、乳香40g、海马4g、樟脑20g、麝香10g、冰片45g、橡胶900g、汽油2800g、明胶150g、聚丙烯酸钠10g、甘油15g、酒石酸10g、甘羟铝10g、丙二醇10g、阿拉伯胶250g、羊毛脂100g、氧化锌1000g、凡士林200g份、松香1000g和水杨酸甲酯20g。
本实施例还提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并用85%的乙醇渗漉至渗漉液无色,得到渗漉液,将渗漉液与滤液混合并浓缩至相对密度于60℃时为1.03,得到浸膏,向胶浆内加入羊毛脂、氧化锌、凡士林、松香、水杨酸甲酯、樟脑、麝香和冰片制成膏体,向膏体内加入橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混匀,得到胶浆,将胶浆涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。
实施例2
本实施例提供了一种用于治疗风湿的巴布贴剂,包括如下原料,马钱子350g、荆芥35g、当归65g、红花35g、牛膝35g、木瓜35g、防已35g、赤芍35g、防风50g、甘草35g、川芎35g、天麻35g、杜仲35g、没药50g、肉桂20g、乳香50g、海马8g、樟脑30g、麝香15g、冰片55g、橡胶1100g、汽油3200g、明胶200g、聚丙烯酸钠20g、甘油30g、酒石酸30g、甘羟铝20g、丙二醇20g、阿拉伯胶300g、羊毛脂150g、氧化锌1250g、凡士林300g份、松香1050g和水杨酸甲酯30g。
本实施例还提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并用95%的乙醇渗漉至渗漉液无色,得到渗漉液,将渗漉液与滤液混合并浓缩至相对密度于60℃时为1.10,得到浸膏,向胶浆内加入羊毛脂、氧化锌、凡士林、松香、水杨酸甲酯、樟脑、麝香和冰片制成膏体,向膏体内加入橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混匀,得到胶浆,将胶浆涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。
实施例3
本实施例提供了一种用于治疗风湿的巴布贴剂,包括如下原料,马钱子300g、荆芥30g、当归60g、红花30g、牛膝30g、木瓜30g、防已30g、赤芍30g、防风45g、甘草30g、川芎30g、天麻30g、杜仲30g、没药45g、肉桂15g、乳香45g、海马6g、樟脑25g、麝香12.5g、冰片50g、水杨酸甲酯25g、橡胶1000g、汽油3000g、明胶175g、聚丙烯酸钠15g、甘油20g、酒石酸20g、甘羟铝15g、丙二醇15g、阿拉伯胶250g、毛脂125g、氧化锌1125g、凡士林250g和松香1025g。
本实施例还提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并用90%的乙醇渗漉至渗漉液无色,得到渗漉液,将渗漉液与滤液混合并浓缩至相对密度于60℃时为1.06,得到浸膏,向胶浆内加入羊毛脂、氧化锌、凡士林、松香、水杨酸甲酯、樟脑、麝香和冰片制成膏体,向膏体内加入橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混匀,得到胶浆,将胶浆涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。
实施例4
本实施例提供了一种用于治疗风湿的巴布贴剂,包括如下原料,马钱子280g、荆芥28g、当归58g、红花28g、牛膝28g、木瓜28g、防已28g、赤芍28g、防风43g、甘草28g、川芎29g、天麻28g、杜仲28g、没药43g、肉桂14g、乳香44g、海马5g、樟脑24g、麝香12g、冰片48g、水杨酸甲酯24g、橡胶985g、汽油2850g、明胶170g、聚丙烯酸钠16g、甘油23g、酒石酸21g、甘羟铝16g、丙二醇16g、阿拉伯胶220g、毛脂120g、氧化锌1120g、凡士林240g和松香1010g。
本实施例还提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并用88%的乙醇渗漉至渗漉液无色,得到渗漉液,将渗漉液与滤液混合并浓缩至相对密度于60℃时为1.05,得到浸膏,向胶浆内加入羊毛脂、氧化锌、凡士林、松香、水杨酸甲酯、樟脑、麝香和冰片制成膏体,向膏体内加入橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混匀,得到胶浆,将胶浆涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。
实施例5
本实施例提供了一种用于治疗风湿的巴布贴剂,包括如下原料,马钱子310g、荆芥31g、当归61g、红花31g、牛膝31g、木瓜31g、防已31g、赤芍31g、防风46g、甘草31g、川芎31g、天麻31g、杜仲31g、没药46g、肉桂16g、乳香46g、海马7g、樟脑26g、麝香13g、冰片51g、水杨酸甲酯26g、橡胶1020g、汽油3070g、明胶182g、聚丙烯酸钠14g、甘油19g、酒石酸18g、甘羟铝13g、丙二醇14g、阿拉伯胶264g、毛脂128g、氧化锌1128g、凡士林253g和松香1040g。
本实施例还提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并用92%的乙醇渗漉至渗漉液无色,得到渗漉液,将渗漉液与滤液混合并浓缩至相对密度于60℃时为1.08,得到浸膏,向胶浆内加入羊毛脂、氧化锌、凡士林、松香、水杨酸甲酯、樟脑、麝香和冰片制成膏体,向膏体内加入橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混匀,得到胶浆,将胶浆涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。
实施例6
本实施例提供了一种用于治疗风湿的巴布贴剂,包括如下原料,马钱子274g、荆芥29g、当归63g、红花33g、牛膝29g、木瓜27g、防已33g、赤芍33g、防风47g、甘草32g、川芎33g、天麻29g、杜仲34g、没药48g、肉桂16g、乳香43g、海马4.5g、樟脑27g、麝香13.5g、橡胶1011g、汽油3079g、明胶191g、聚丙烯酸钠17g、甘油22g、酒石酸17g、甘羟铝14g、丙二醇18g、阿拉伯胶272g和冰片54g。
本实施例还提供了一种用于治疗风湿的巴布贴剂的制备方法,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与滤渣混合并用94%的乙醇渗漉至渗漉液无色,得到渗漉液,将渗漉液与滤液混合并浓缩至相对密度于60℃时为1.09,得到浸膏,向浸膏内加入樟脑、麝香和冰片制成膏体,向膏体内加入橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混匀,得到胶浆,将胶浆涂于背衬上并晾干即得到用于治疗风湿的巴布贴剂。
试验例1
取实施例1-6所制得的用于治疗风湿的巴布贴剂照橡胶膏剂含膏量测定法(中国药典2010年版一部附录I Q)测定,用乙醚作溶剂。所得结果如表1所示。
表1含膏量检测结果
根据表1结果所示,实施例1-6所制得的用于治疗风湿的巴布贴剂的含膏量均大于1.8g/100cm2,因此,实施例1-6所制得的巴布贴剂的含膏量均符合国家标准。
试验例2
取实施例1-6所制得的用于治疗风湿的巴布贴剂分别剪成条状并除去盖衬,置500ml烧瓶中,加1mol/L盐酸溶液70ml,回流提取2小时,分取盐酸溶液,用浓氨水调节pH值11-12,再用三氯甲烷提取3次,每次20ml,合并三氯甲烷提取液,蒸干,残渣用甲醇溶解并转移到25ml容量瓶中,加甲醇至刻度,摇匀,滤过,取续滤液,即得供试品溶液,精密称取士的宁对照品适量,加甲醇制成每1ml含10μg的溶液,即得对照品溶液,分别精密吸取对照品溶液和供试品溶液各5-20μl,注入液相色谱仪(以十八烷基硅烷键合硅胶为填充剂;以乙腈-0.01mol/L庚烷磺酸钠与0.02mol/L磷酸二氢钾等量混合溶液(用10%磷酸调节pH值2.8)(25:85)为流动相;检测波长为260nm),测定。所测得的实施例1-6中所制得的用于治疗风湿的巴布贴剂中含士的宁(C21H22N2O2)的量的结果如表2所示。
表2士的宁含量表
根据表2结果所示,实施例1-6所制得的用于治疗风湿的巴布贴剂中士的宁的含量符合《中国药典》2010年版一部附录VID中士的宁的含量区间(0.015-0.25mg(7cm×10cm))。
试验例3
丁先生,男,24岁,因工作原因患有长期的风湿骨痛,常常疼痛难忍,导致夜晚难以入眠,甚至脚踝关节变形,在长期外敷本发明所制得的贴剂连续半年后(每周外敷3-4次),关节变形症状有明显改善,且风湿病未再发作,一年后回访未复发。
何先生,男,34岁,因打球脚崴之后,康复后该处就患有长期的风湿症状,每次下雨夜晚疼痛难忍,在长期外敷本发明所制得的贴剂连续两个月后(每周外敷3-4次),风湿症状有明显改善,几乎无疼痛感,三个月后回访未复发。
综上所述,本发明实施例提供了一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂,
一、本发明的实施例提供了一种用于治疗风湿的巴布贴剂的制备方法,该方法通过加入菌液对马钱子进行发酵,以降低马钱子的毒性和刺激性,方便患者敷用,并通过加入酸液酸化、碱液碱化和氯仿萃取以对马钱子中的生物碱进行提纯,从而增大所制得的巴布贴剂中有益成分的浓度,进而提高巴布贴剂的疗效。
二、本发明的实施例还提供了一种用于治疗风湿的巴布贴剂,该巴布贴剂通过合理的君臣佐使关系进行配伍,从而在保证了该贴剂具有较好的祛风除湿、活血通络效果的同时,还能够降低该贴剂的刺激性,从而降低患者使用时的痛感,并且由于该贴剂还能够起到强筋健骨的作用,因此能够缩短患者的治疗疗程,进而加快患者的康复时间。
以上所描述的实施例是本发明一部分实施例,而不是全部的实施例。本发明的实施例的详细描述并非旨在限制要求保护的本发明的范围,而是仅仅表示本发明的选定实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
Claims (10)
1.一种用于治疗风湿的巴布贴剂的制备方法,其特征在于,包括如下步骤,将海马粉碎后依次煎煮和过滤,分别得到滤液和滤渣,将马钱子、荆芥、当归、红花、牛膝、木瓜、防已、赤芍、防风、甘草、川芎、天麻、杜仲、没药、肉桂和乳香粉碎后与所述滤渣混合并渗漉,得到渗漉液,将所述渗漉液与所述滤液混合并浓缩,得到浸膏,向所述浸膏内加入樟脑、麝香和冰片制成膏体,将所述膏体与胶料混合后涂于背衬上并晾干即得到所述用于治疗风湿的巴布贴剂。
2.根据权利要求1所述的用于治疗风湿的巴布贴剂,其特征在于,所述胶料包括如下原料,橡胶、明胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、阿拉伯胶和汽油;
所述胶料制备包括如下步骤,将所述橡胶、阿拉伯胶、聚丙烯酸钠、甘油、酒石酸、甘羟铝、丙二醇、明胶和汽油混合后搅匀,即得到所述胶料。
3.根据权利要求1所述的用于治疗风湿的巴布贴剂,其特征在于,所述制成膏体还包括加入添加剂,所述加入添加剂包括如下步骤,将所述添加剂、浸膏、樟脑、麝香和冰片混匀后即得到所述膏体;所述添加剂包括如下原料,羊毛脂、氧化锌、凡士林、松香和水杨酸甲酯。
4.根据权利要求1所述的用于治疗风湿的巴布贴剂,其特征在于,所述渗漉采用85-95%的乙醇溶液。
5.根据权利要求1所述的用于治疗风湿的巴布贴剂,其特征在于,所述浸膏的相对密度在60℃时为1.03-1.10。
6.一种用于治疗风湿的巴布贴剂,其特征在于,由权利要求1-5任意一项所述的一种用于治疗风湿的巴布贴剂的制备方法制得。
7.根据权利要求6所述的用于治疗风湿的巴布贴剂,其特征在于,包括按重量分数计的如下原料,马钱子250-350份、荆芥25-35份、当归55-65份、红花25-35份、牛膝25-35份、木瓜25-35份、防已25-35份、赤芍25-35份、防风40-50份、甘草25-35份、川芎25-35份、天麻25-35份、杜仲25-35份、没药40-50份、肉桂10-20份、乳香40-50份、海马4-8份、樟脑20-30份、麝香10-15份、胶料4105-4920份和冰片45-55份。
8.根据权利要求7所述的用于治疗风湿的巴布贴剂,其特征在于,所述胶料包括按重量份数计的如下原料,橡胶900-1100份、阿拉伯胶200-300份、聚丙烯酸钠10-20份、甘油15-30份、酒石酸10-30份、甘羟铝10-20份、丙二醇10-20份、明胶150-200份和汽油2800-3200份。
9.根据权利要求8所述的用于治疗风湿的巴布贴剂,其特征在于,还包括添加剂,所述添加剂包括按重量份数计的如下原料,羊毛脂100-150份、氧化锌1000-1250份、凡士林200-300份、松香1000-1050份和水杨酸甲酯20-30份。
10.根据权利要求9所述的用于治疗风湿的巴布贴剂,其特征在于,包括如下重量份原料,马钱子300份、荆芥30份、当归60份、红花30份、牛膝30份、木瓜30份、防已30份、赤芍30份、防风45份、甘草30份、川芎30份、天麻30份、杜仲30份、没药45份、肉桂15份、乳香45份、海马6份、樟脑25份、麝香12.5份、冰片50份、水杨酸甲酯25份、橡胶1000份、汽油3000份、明胶175份、聚丙烯酸钠15份、甘油20份、酒石酸20份、甘羟铝15份、丙二醇15份、阿拉伯胶250份、毛脂125份、氧化锌1125份、凡士林250份和松香1025份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111469225.8A CN114129669A (zh) | 2021-12-03 | 2021-12-03 | 一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111469225.8A CN114129669A (zh) | 2021-12-03 | 2021-12-03 | 一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114129669A true CN114129669A (zh) | 2022-03-04 |
Family
ID=80387545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111469225.8A Pending CN114129669A (zh) | 2021-12-03 | 2021-12-03 | 一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114129669A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1945309A (zh) * | 2006-10-09 | 2007-04-11 | 林冶 | 精制海马追风膏中马钱子碱和士的宁的含量测定方法 |
CN101020003A (zh) * | 2007-03-06 | 2007-08-22 | 林冶 | 精制海马追风巴布膏及其制备方法 |
CN105434900A (zh) * | 2015-12-17 | 2016-03-30 | 重庆希尔安药业有限公司 | 一种用于驱风活血、散寒止痛的中药组合物及其制备方法 |
-
2021
- 2021-12-03 CN CN202111469225.8A patent/CN114129669A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1945309A (zh) * | 2006-10-09 | 2007-04-11 | 林冶 | 精制海马追风膏中马钱子碱和士的宁的含量测定方法 |
CN101020003A (zh) * | 2007-03-06 | 2007-08-22 | 林冶 | 精制海马追风巴布膏及其制备方法 |
CN105434900A (zh) * | 2015-12-17 | 2016-03-30 | 重庆希尔安药业有限公司 | 一种用于驱风活血、散寒止痛的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103169928B (zh) | 治疗痛经的外用中药组合物及其制备方法和应用 | |
CN103479775B (zh) | 一种刮痧油及其制备方法 | |
CN101244221A (zh) | 一种皮肤外用组合物及其制法 | |
CN107693767B (zh) | 一种防治糖尿病足的外用中药组合物、其制备方法及应用 | |
CN103316146B (zh) | 一种麻醉用中药制剂 | |
CN105963664A (zh) | 一种消炎镇痛膏药组合物及贴膏剂 | |
CN110548092A (zh) | 一种活血舒络中药组合物及其制备方法 | |
CN113768975A (zh) | 一种治疗关节疼痛的中药组合物、中药贴剂及其制备方法与使用方法 | |
CN105641660A (zh) | 一种治疗冻疮的中药组合物及其制备方法 | |
CN114129669A (zh) | 一种用于治疗风湿的巴布贴剂的制备方法及其巴布贴剂 | |
CN114306436A (zh) | 一种用于治疗骨关节疼痛的中药组合物巴布剂及制备方法 | |
CN112957441A (zh) | 一种祛风除湿、温通经络、活血止痛的外用药膜涂膜剂及其制备方法 | |
CN111603528A (zh) | 一种用于治疗痛症和调理经络的外用药物及其制备方法 | |
CN105561270A (zh) | 一种外敷止痛中草药及其制备方法 | |
CN100346821C (zh) | 治疗肝胆病的药物胶囊及其制备方法 | |
CN103028049B (zh) | 一种治疗鹅掌风的中药组合物及制备方法 | |
CN112755101B (zh) | 一种治疗膝骨关节炎的中药组合物及其应用 | |
CN114504614B (zh) | 一种软组织损伤的中药组合物与一种中药膏剂及其制备方法 | |
CN113384633B (zh) | 用于治疗湿疹的中药组合物 | |
CN104940869A (zh) | 治疗颈肩腰腿疼、陈旧性损伤的中药组合物及其制备方法 | |
CN110876792A (zh) | 龙脑舒筋活络贴 | |
CN113925846A (zh) | 一种适用于急性软组织损伤的黑膏药及其制备方法 | |
CN111298066A (zh) | 一种汉方草本植物精华素的中药组合物及制备方法和应用 | |
CN111012887A (zh) | 一种活血化瘀膏及其制备方法和应用 | |
CN114191517A (zh) | 一种治疗阳虚寒凝型膝骨关节炎的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220304 |